课题基金 / 基金详情

Isolation and analysis of new genes that regulate the actin cytoskeleton system

Isolation and analysis of new genes that regulate the actin cytoskeleton system
调节肌动蛋白细胞骨架系统的新基因的分离和分析
批准号:
11480205
负责人:
TANAKA Kazuma
金额:
$7.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TANAKA Kazuma的其他基金

相似基金

相关文献

中文摘要
翻译
肌动蛋白细胞骨架系统在细胞运动、细胞间黏附、细胞极性形成、细胞形态变化等方面发挥着重要作用。I型肌球蛋白是一种不依赖肌动蛋白的运动蛋白,参与肌动蛋白细胞骨架的重组和内吞作用。Myo3p和Myo5p是发芽酵母中的I型肌球蛋白。在这项研究中,我们分离了一个新的基因CDC50,作为myo5突变体的多拷贝抑制基因。Cdc50突变体最初被鉴定为细胞分裂周期停滞的突变体,但其功能尚未确定。CDC50编码一个具有跨膜结构域的膜蛋白。生化实验表明,CDC50P是一种完整的膜蛋白。对表达CDC50-GFP的细胞的显微镜观察表明,CDC50定位于内体,提示CDC50参与了通过内体的蛋白质或脂类运输。Cdc50突变体表现出冷敏感的生长表型,细胞停滞在小芽期,这表明cdc50p调节细胞极化。对cdc50突变体中肌动蛋白细胞骨架的可视化显示,在cdc50突变体中肌动蛋白斑块被非局部化。我们的结果表明,CDC50调节一种与肌动蛋白细胞骨架极化有关的蛋白质到质膜的运输。
英文摘要
The actin cytoskeleton system plays an important role in cell motility, cell-cell adhesion, formation of cell polarity, and cell morphological change. Type I myosins are actindependent motor proteins and are involved in the reorganization of the actin cytoskeleton and endocytosis. Myo3p and Myo5p are the type I myosins in the budding yeast Saccharomyces cerevisiae. In this study, we have isolated a new gene, CDC50, as a multicopy suppressor of the myo5 mutant. The cdc50 mutant was first characterized as a mutant which show cell division cycle arrest, but its functions has not been characterized yet. CDC50 encodes a putative membrane protein that possesses a transmembrane domain. Biochemical experiments indicate that Cdc50p is an integral membrane protein. Microscopic observation of cells expressing CDC50-GFP indicates that CDC50 is localized to endosomes, suggesting that CDC50 is involved in the protein or lipid traffic through endosomes. The cdc50 mutant shows a coldsensitive growth phenotype and cells are arrested at small-budded stage, suggesting that Cdc50p regulates cell polarization. Visualization of the actin cytoskeleton in the cdc50 mutant revealed that actin patches are delocalized in the cdc50 mutant. Our results indicate that CDC50 regulates a traffic to the plasma membrane of a protein that is involved in the polarization of the actin cytoskeleton.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujiwara, T., Tanaka, K., Inoue, E., Kikyo, M., and Takai, Y.: "The formin Bnilp regulates microtubule-dependent nuclear migration through the actin cytoskeleton in Saccharomyces cerevisiae"Mol.Cell.Biol.. 19. 8016-8027 (1999)
Fujiwara, T.、Tanaka, K.、Inoue, E.、Kikyo, M. 和 Takai, Y.:“formin Bnilp 通过酿酒酵母中的肌动蛋白细胞骨架调节微管依赖性核迁移”Mol.Cell.Biol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kikyo,M.,Tanaka,K, et al: "An FH1 domain-containing Bnr1p is a multifunctional protein interacting with a variety of cytoskeletal proteins in Saccharomyces cerevisiae"Oncogene. Vol18. 7046-7054 (1999)
Kikyo,M.,Tanaka,K 等人:“含有 FH1 结构域的 Bnr1p 是一种与酿酒酵母中多种细胞骨架蛋白相互作用的多功能蛋白”癌基因。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka, K.: "Formin family proteins in cytoskeletal control"Biochem.Biophys.Res.Commun.. Vol 267. 479-481 (2000)
Tanaka, K.:“细胞骨架控制中的 Formin 家族蛋白”Biochem.Biophys.Res.Commun.. Vol 267. 479-481 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 10 条
    Studies on cell functions regulated by changes in membrane phospholipid asymmetry
    • 批准号:
      21370085
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2009
    • 负责人:
      TANAKA Kazuma
    • 依托单位:
    Roles for phospholipid asymmetry in cell polarity
    • 批准号:
      15370081
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.62万
    • 财政年份:
      2003
    • 负责人:
      TANAKA Kazuma
    • 依托单位:
    Development of a new screening system for drugs that modify the signaling pathways regulating the actin cytoskeleton
    • 批准号:
      11557008
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $7.04万
    • 财政年份:
      1999
    • 负责人:
      TANAKA Kazuma
    • 依托单位:
    Analysis of the Rho small GTP-binding proteinmediated signaling cascade
    海外基金